Kit S, Sheppard M, Ichimura H, Kit M
Am J Vet Res. 1987 May;48(5):780-93.
A modified-live pseudorabies virus (PRV) vaccine, designated PRV(dlg92/d1tk), with deletions in the thymidine kinase (tk) and glycoprotein-gIII (g92) genes, was derived from the PRV (Bucharest [BUK]-d13) vaccine strain. The vaccine virus also contained a deletion in glycoprotein gI. Despite 3 deletions, PRV(dlg92/d1tk) replicated to high titers in cell culture from 30 C to 39.1 C. Enzyme assays and autoradiography revealed that PRV(dlg92/d1tk) did not induce a functional tk activity in infected tk- RAB(BU) cells (rabbit skin). Rabbit skin cells were infected with PRV(dlg92/d1tk), with vaccine strains derived from BUK or Bartha K strains of PRV or with the virulent Illinois (ILL), Indiana-Funkhauser (IND-F), and Aujeszky (Auj) strains of PRV and were labeled with [3H]mannose from 4 or 5 to 24 hours after infection to investigate whether these viruses induced the synthesis of glycoprotein gIII. Nonionic detergent extracts were prepared and immunoprecipitated with antisera from pigs vaccinated with tk(-)-PRV(BUK-d13) or tk+-Bartha K, pigs vaccinated with tk+-PRV(BUK) strains and then challenge exposed to tk+-PRV(IND-F), naturally infected domestic or feral pigs, and pigs vaccinated with tk-)-PRV(dlg92/d1tk). Mouse monoclonal antibodies against PRV glycoproteins gIII, gp50, and gII were also studied. After immunoprecipitation, labeled PRV-specific proteins were analyzed by sodium dodecylsulfate-polyacrylamide gel electrophoresis and autoradiography. The PRV glycoprotein-gII complex, but not glycoprotein gIII, was synthesized in PRV(dlg92/d1tk)-infected cells. Glycoprotein gII and gIII were made in cells infected with PRV vaccine strains BUK, Bartha K, and BUK-d13 and with virulent PRV strains ILL, IND-F, and Auj. Cells infected with PRV(dlg92/d1tk) and with PRV strains ILL, IND-F, Auj, Bartha K, BUK, and BUK-d13, excreted into the cell culture medium a highly sulfated glycoprotein gX of about 90 kilodaltons. Antibodies to glycoprotein gIII were not detected in the sera of pigs inoculated with PRV(dlg92/d1tk), but were found in all other swine sera.
一种改良活伪狂犬病病毒(PRV)疫苗,命名为PRV(dlg92/d1tk),其胸苷激酶(tk)基因和糖蛋白gIII(g92)基因存在缺失,源自PRV(布加勒斯特[BUK]-d13)疫苗株。该疫苗病毒的糖蛋白gI也存在缺失。尽管有3处缺失,PRV(dlg92/d1tk)在30℃至39.1℃的细胞培养中仍能复制至高滴度。酶分析和放射自显影显示,PRV(dlg92/d1tk)在感染的tk - RAB(BU)细胞(兔皮肤)中未诱导出功能性tk活性。用PRV(dlg92/d1tk)、源自PRV的BUK或Bartha K株的疫苗株、或PRV的强毒株伊利诺伊(ILL)、印第安纳 - 芬克豪泽(IND - F)和奥耶斯基(Auj)株感染兔皮肤细胞,并在感染后4或5至24小时用[3H]甘露糖标记,以研究这些病毒是否诱导糖蛋白gIII的合成。制备非离子去污剂提取物,并用接种tk(-)-PRV(BUK - d13)或tk + - Bartha K的猪的抗血清、接种tk + - PRV(BUK)株然后用tk + - PRV(IND - F)攻击暴露的猪的抗血清、自然感染的家猪或野猪的抗血清以及接种tk -)-PRV(dlg92/d1tk)的猪的抗血清进行免疫沉淀。还研究了针对PRV糖蛋白gIII、gp50和gII的小鼠单克隆抗体。免疫沉淀后,通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳和放射自显影分析标记的PRV特异性蛋白。在PRV(dlg92/d1tk)感染的细胞中合成了PRV糖蛋白 - gII复合物,但未合成糖蛋白gIII。在感染PRV疫苗株BUK、Bartha K和BUK - d13以及强毒株PRV株ILL、IND - F和Auj的细胞中合成了糖蛋白gII和gIII。用PRV(dlg92/d1tk)以及PRV株ILL、IND - F、Auj、Bartha K、BUK和BUK - d13感染的细胞,将一种约90千道尔顿的高度硫酸化糖蛋白gX分泌到细胞培养基中。接种PRV(dlg92/d1tk)的猪血清中未检测到针对糖蛋白gIII的抗体,但在所有其他猪血清中均发现了该抗体。